Literature DB >> 25707816

Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma.

Mark A Rettenmaier1, Alberto A Mendivil, Crystal M Gray, Amber P Chapman, Michelle K Stone, Erin J Tinnerman, Bram H Goldstein.   

Abstract

PURPOSE: Hyperthermic intraperitoneal chemotherapy (HIPEC) involves the continuous heating and circulation of chemotherapy throughout the abdominal cavity in an attempt to enhance cytotoxicity. Despite the potential of this chemotherapy procedure, there are scant anatomical temperature distribution studies reporting on this therapeutic process. PATIENTS AND METHODS: We prospectively evaluated the temperature of select anatomical (e.g. upper abdominal, mid-abdominal and supra-pubic) sites in 11 advanced stage ovarian cancer patients who were treated with consolidation HIPEC carboplatin (AUC 10). The temperature of the aforementioned anatomical regions and the inflow/outflow tubing was measured at baseline and at 15-min intervals until the procedure's completion.
RESULTS: The lowest observed mean composite temperature was 41.1 °C at the supra-pubic site whereas the highest temperature was 42.6 °C, in association with the inflow/outflow tubing. During the various time intervals we also ascertained that the lowest composite temperature was 40.9 °C at baseline (i.e. time 0), whereas the highest value (41.8 °C) occurred at multiple time periods (e.g., 15, 45 and 60 min).
CONCLUSION: The HIPEC temperature variation amongst the various abdominal sites and time intervals was minimal. We also discerned that uniform temperature distribution throughout the abdominal cavity was facilitated when the abdomen was both maximally distended with fluid and a high flow rate was maintained.

Entities:  

Keywords:  Carboplatin; HIPEC; intra-abdominal heat distribution; ovarian cancer

Mesh:

Substances:

Year:  2015        PMID: 25707816     DOI: 10.3109/02656736.2015.1007399

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  5 in total

1.  Risk of Intraoperative Hyperthermia and Outcomes in Adults Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Carlos E Guerra-Londono; Pascal Owusu-Agyemang; German Corrales; Marina M Rofaeil; Lei Feng; Keith Fournier; Juan P Cata
Journal:  Ann Surg Oncol       Date:  2021-10-26       Impact factor: 5.344

2.  New experimental model for single liver lobe hyperthermia in small animals using non-directional microwaves.

Authors:  Ionuț Tudorancea; Vlad Porumb; Alexandru Trandabăţ; Decebal Neaga; Bogdan Tamba; Radu Iliescu; Gabriel M Dimofte
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

3.  A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function.

Authors:  Jinning Ye; Liuhua Chen; Jidong Zuo; Jianjun Peng; Chuangqi Chen; Shirong Cai; Wu Song; Yulong He; Yujie Yuan
Journal:  Cancer Biol Ther       Date:  2020-06-17       Impact factor: 4.742

4.  A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats.

Authors:  Daan R Löke; Roxan F C P A Helderman; Jan Sijbrands; Hans M Rodermond; Pieter J Tanis; Nicolaas A P Franken; Arlene L Oei; H Petra Kok; Johannes Crezee
Journal:  Cancers (Basel)       Date:  2020-11-26       Impact factor: 6.639

5.  In-vivo thermodynamic exploration of gas-based intraperitoneal hyperthermia.

Authors:  Agata Diakun; Tanja Khosrawipour; Agata Mikolajczyk-Martinez; Piotr Kuropka; Jakub Nicpoń; Zdzisław Kiełbowicz; Przemysław Prządka; Bartłomiej Liszka; Shiri Li; Hien Lau; Wojciech Kielan; Veria Khosrawipour
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.